153 related articles for article (PubMed ID: 11090988)
1. Similar potency of the enantiomers of huperzine A in inhibition of [(3)H]dizocilpine (MK-801) binding in rat cerebral cortex.
Zhang YH; Chen XQ; Yang HH; Jin GY; Bai DL; Hu GY
Neurosci Lett; 2000 Dec; 295(3):116-8. PubMed ID: 11090988
[TBL] [Abstract][Full Text] [Related]
2. Spermidine antagonizes the inhibitory effect of huperzine A on [3H]dizocilpine (MK-801) binding in synaptic membrane of rat cerebral cortex.
Zhang YH; Zhao XY; Chen XQ; Wang Y; Yang HH; Hu GY
Neurosci Lett; 2002 Feb; 319(2):107-10. PubMed ID: 11825682
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of cholinesterase inhibitors on [3H]MK-801 binding in rat cerebral cortex.
Wang XD; Chen XQ; Yang HH; Hu GY
Neurosci Lett; 1999 Sep; 272(1):21-4. PubMed ID: 10507533
[TBL] [Abstract][Full Text] [Related]
4. Modulation of NMDA receptor by huperzine A in rat cerebral cortex.
Wang XD; Zhang JM; Yang HH; Hu GY
Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):31-5. PubMed ID: 10437121
[TBL] [Abstract][Full Text] [Related]
5. Huperzine A, a nootropic alkaloid, inhibits N-methyl-D-aspartate-induced current in rat dissociated hippocampal neurons.
Zhang JM; Hu GY
Neuroscience; 2001; 105(3):663-9. PubMed ID: 11516831
[TBL] [Abstract][Full Text] [Related]
6. Stereoselectivities of enantiomers of huperzine A in protection against beta-amyloid(25-35)-induced injury in PC12 and NG108-15 cells and cholinesterase inhibition in mice.
Zhang HY; Liang YQ; Tang XC; He XC; Bai DL
Neurosci Lett; 2002 Jan; 317(3):143-6. PubMed ID: 11755260
[TBL] [Abstract][Full Text] [Related]
7. Potencies and stereoselectivities of enantiomers of huperzine A for inhibition of rat cortical acetylcholinesterase.
McKinney M; Miller JH; Yamada F; Tuckmantel W; Kozikowski AP
Eur J Pharmacol; 1991 Oct; 203(2):303-5. PubMed ID: 1800123
[TBL] [Abstract][Full Text] [Related]
8. Huperzine A attenuates amyloid beta-peptide fragment 25-35-induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation.
Xiao XQ; Zhang HY; Tang XC
J Neurosci Res; 2002 Jan; 67(1):30-6. PubMed ID: 11754078
[TBL] [Abstract][Full Text] [Related]
9. The NMDA receptor ion channel: a site for binding of Huperzine A.
Gordon RK; Nigam SV; Weitz JA; Dave JR; Doctor BP; Ved HS
J Appl Toxicol; 2001 Dec; 21 Suppl 1():S47-51. PubMed ID: 11920920
[TBL] [Abstract][Full Text] [Related]
10. Preservation of redox, polyamine, and glycine modulatory domains of the N-methyl-D-aspartate receptor in Alzheimer's disease.
Palmer AM; Burns MA
J Neurochem; 1994 Jan; 62(1):187-96. PubMed ID: 8263519
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease.
Wang R; Tang XC
Neurosignals; 2005; 14(1-2):71-82. PubMed ID: 15956816
[TBL] [Abstract][Full Text] [Related]
12. NMDA recepter-mediated neuroprotection by essential oils from the rhizomes of Acorus gramineus.
Cho J; Kong JY; Jeong DY; Lee KD; Lee DU; Kang BS
Life Sci; 2001 Feb; 68(13):1567-73. PubMed ID: 11253173
[TBL] [Abstract][Full Text] [Related]
13. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
[TBL] [Abstract][Full Text] [Related]
14. Long term depletion of serotonin leads to selective changes in glutamate receptor subunits.
Shutoh F; Hamada S; Shibata M; Narita M; Shiga T; Azmitia EC; Okado N
Neurosci Res; 2000 Dec; 38(4):365-71. PubMed ID: 11164563
[TBL] [Abstract][Full Text] [Related]
15. Huperzine A, a nootropic agent, inhibits fast transient potassium current in rat dissociated hippocampal neurons.
Li Y; Hu GY
Neurosci Lett; 2002 May; 324(1):25-8. PubMed ID: 11983286
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
[TBL] [Abstract][Full Text] [Related]
17. [Effects of (-), (+) clausenamide on central N-methyl-D-asparate receptors in rodents].
Duan WZ; Zhang JT
Yao Xue Xue Bao; 1997 Apr; 32(4):259-63. PubMed ID: 11499027
[TBL] [Abstract][Full Text] [Related]
18. Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease.
Friedli MJ; Inestrosa NC
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770940
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholinesterase inhibition and protection by dizocilpine (MK-801) enantiomers.
Galli A; Mori F
J Pharm Pharmacol; 1996 Jan; 48(1):71-6. PubMed ID: 8722500
[TBL] [Abstract][Full Text] [Related]
20. Dantrolene antagonizes the glycineB site of the NMDA receptor.
Salinska E; Sobczuk A; Lazarewicz JW
Neurosci Lett; 2008 Feb; 432(2):137-40. PubMed ID: 18191027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
